Recent insights suggest that a low-carbohydrate diet could significantly boost beta-cell function, thereby enhancing insulin sensitivity in individuals with mild type 2 diabetes. Beta cells, nestled within the pancreas, are pivotal for insulin production, which is essential for regulating blood sugar levels. For individuals grappling with type 2 diabetes, these cells often underperform, a deficiency that can be exacerbated by high carbohydrate intake. The interplay between faltering beta-cell activity and insulin resistance is a driving force behind the onset and escalation of type 2 diabetes.
In a recent study, researchers explored the potential of a low-carb diet to improve beta-cell function in adults with mild type 2 diabetes, offering a promising avenue for managing the condition without medication. This study was meticulously conducted as a randomised controlled trial involving 57 adults aged 35 to 65, who had been diagnosed with mild type 2 diabetes within the previous decade. Participants were either managing their condition through diet or medication but were not on insulin therapy. To ensure accurate baseline testing, participants were asked to halt their medications one to two weeks prior.
Participants were then split into two dietary groups for a period of 12 weeks: one group followed a reduced carbohydrate diet comprising approximately 9% carbohydrates and 65% fat, while the other adhered to a higher carbohydrate diet with about 55% carbohydrates and 20% fat. These diets were crafted by registered dietitians to be “eucaloric,” meaning they provided the exact caloric intake required to maintain each participant’s body weight. This careful design allowed researchers to isolate the effects of carbohydrate reduction on beta-cell performance.
Throughout the study, participants received daily meals, comprehensive meal plans, and engaged in weekly consultations with dietitians. The researchers employed advanced techniques like the hyperglycaemic clamp and oral glucose tolerance tests to assess beta-cell function and insulin release both at the start and conclusion of the trial.
A few participants resumed their metformin medication during the study—two from the high-carb group and one from the low-carb group—but their data remained part of the final analysis. The results were illuminating. After the 12-week period, significant improvements in beta-cell function and insulin release were observed among those on the low-carb diet compared to their high-carb counterparts. Specifically, those on the low-carb diet exhibited improvements in both initial (rapid) and maximal beta-cell responses that were twofold and 22% greater, respectively.
The oral glucose tolerance test further revealed a 32% enhancement in insulin’s effectiveness on blood glucose levels among those on the low-carb diet after 12 weeks. Interestingly, racial differences emerged in the response to dietary intervention: Black participants following a low-carb diet experienced a 110% greater improvement in rapid beta-cell response compared to those on a high-carb diet, an effect not seen in white participants. Conversely, white participants saw a 48% greater improvement in maximal beta-cell response compared to their Black peers.
The authors of the study suggest that these differences might stem from inherent biological variations in beta-cell functionality between different racial groups. Black adults may exhibit a more immediate insulin response to glucose than white adults, despite similar levels of insulin sensitivity.
The study concludes that while carbohydrate restriction might present challenges for some patients, it offers a pathway for those with mild type 2 diabetes to potentially discontinue medication while enjoying meals that meet their energy needs and enhance beta-cell function—a feat not achievable through medication alone.
Notably, the study found minimal changes in insulin sensitivity across both dietary interventions, indicating that improvements in beta-cell response linked to the low-carb diet were likely due to factors other than shifts in insulin sensitivity.
Seeking further understanding, experts from various medical institutions provided insights into how a low-carb diet might bolster beta-cell function. They explained that reducing carbohydrate intake decreases glucose entry into the bloodstream, lessening the strain on beta-cells to produce insulin and potentially reversing some dysfunction caused by glucose toxicity. This benefit is more pronounced in individuals with mild diabetes but could extend to those with prediabetes or more advanced stages of diabetes, though the extent of improvement may vary.
Yet, experts warn that adherence to a carbohydrate-restricted diet can be challenging, particularly for older adults. To enhance sustainability, they recommend incorporating flexibility in carbohydrate consumption while prioritising whole, unprocessed or minimally processed foods rich in fibre and nutrients. Additionally, maintaining variety and enjoyment in meals, regularly monitoring blood sugar levels—especially when adjusting medications—and consulting healthcare providers can help align dietary changes with individual health needs.
While ketogenic or very low carbohydrate diets can be effective under professional guidance, there is concern over potential rebound effects when reintroducing carbohydrates, which could lead to substantial weight gain and strain on beta-cells.
Dietitians expert generally advise opting for high-fibre, low-carb foods like broccoli, mushrooms, leafy greens, cauliflower, chia seeds, walnuts, ground flaxseed, and almonds to make low-carb diets more sustainable. Fibre slows digestion and enhances satiety, making it easier to adhere to dietary changes.
However, it’s important to recognise that carbohydrate-restricted diets may not suit everyone with type 2 diabetes. Experts emphasise that there is no one-size-fits-all approach. For those for whom a low-carb diet is not ideal, other scientifically backed diets like the Mediterranean and MIND diets could offer benefits. These diets are rich in healthy fats and low in refined carbohydrates such as sugar and flour. Intermittent fasting has also shown promise in reducing glucose levels and improving insulin sensitivity.
Moreover, lifestyle changes like regular physical activity, weight management, mindfulness, and stress reduction have demonstrated potential in improving beta-cell function and overall metabolic health.
While low-carbohydrate diets present a compelling option for enhancing beta-cell function and managing mild type 2 diabetes without medication, they are not universally applicable. Individualised approaches considering personal health needs, preferences, and lifestyle factors are crucial for effective management of this chronic condition. As research continues to evolve, these findings encourage further exploration into dietary strategies as integral components of diabetes care.
